Insider Trading: Biogen Idec Inc (BIIB.O)

BIIB.O on Nasdaq

307.67USD
12:50pm EST
Price Change (% chg)

$2.75 (+0.90%)
Prev Close
$304.92
Open
$307.58
Day's High
$310.20
Day's Low
$305.97
Volume
617,472
Avg. Vol
1,401,913
52-wk High
$358.89
52-wk Low
$270.27

Search Stocks
All Insider Trades
Trading Date Name Title Type Shares Traded Price
10 Nov 2014

Holtzman Steven H

Officer Sell 1,750 $330.00
2 Nov 2014

Scangos George A

Chief Executive Officer Sell 1,128 $320.78
30 Sep 2014

Scangos George A

Chief Executive Officer Sell 1,127 $330.97
30 Sep 2014

Karaboutis (Adriana)

Officer Buy 7,420 $0.00
30 Sep 2014

Holtzman Steven H

Officer Sell 1,750 $330.97
17 Sep 2014

Holtzman Steven H

Officer Gift 500 $0.00
1 Sep 2014

Scangos George A

Chief Executive Officer Sell 1,128 $345.47
31 Jul 2014

Scangos George A

Chief Executive Officer Sell 1,128 $332.93
23 Jul 2014

Posner Brian S

Director Gift 300 $0.00
15 Jul 2014

Scangos George A

Chief Executive Officer Sell 12,316 $312.37
14 Jul 2014

Scangos George A

Chief Executive Officer Sell 10,062 $312.00
14 Jul 2014

Scangos George A

Chief Executive Officer Buy 21,339 $0.00
19 Jun 2014

Posner Brian S

Director Sell 605 $315.00
12 Jun 2014

Posner Brian S

Director Sell 700 $310.50
11 Jun 2014

Pangia Robert W

Director Buy 870 $0.00
11 Jun 2014

Dorsa Caroline D

Director Buy 870 $0.00
11 Jun 2014

Posner Brian S

Director Buy 870 $0.00
11 Jun 2014

Sherwin Stephen A

Director Buy 870 $0.00
11 Jun 2014

Schenk Lynn A

Director Buy 870 $0.00
11 Jun 2014

Leaming Nancy L

Director Buy 870 $0.00
11 Jun 2014

Papadopoulos Stelios B

Director Buy 870 $0.00
11 Jun 2014

Mulligan Richard C

Director Buy 870 $0.00
11 Jun 2014

Denner Alexander J

Director Buy 870 $0.00
11 Jun 2014

Papadopoulos Stelios B

Director Buy 435 $0.00
11 Jun 2014

Rowinsky Eric K

Director Buy 870 $0.00

Institutional Holders

% Shares Owned: 92.36%
# of Holders: 1,097
Total Shares Held: 218,113,818
3 Mo. Net Change: -267,723
# New Positions: 92
# Closed Positions: 59
# Increased Positions: 481
# Reduced Positions: 406
# Net Buyers: 75

Officers & Directors

Name Age Since Current Position

Stelios Papadopoulos

65 2014 Independent Chairman of the Board

George Scangos

66 2010 Chief Executive Officer, Director

Paul Clancy

52 2007 Chief Financial Officer, Executive Vice President - Finance

Kenneth Di Pietro

55 2012 Executive Vice President - Human Resources

Susan Alexander

57 2006 Executive Vice President, Chief Legal Officer and Corporate Secretary

John Cox

51 2010 Executive Vice President - Pharmaceutical Operations and Technology

Steven Holtzman

59 2011 Executive Vice President - Corporate Development

Tony Kingsley

50 2011 Executive Vice President - Global Commercial Operations

Douglas Williams

56 2011 Executive Vice President - Research and Development

Spyros Artavanis-Tsakonas

67 2013 Senior Vice President, Chief Scientific Officer

Adam Koppel

44 2014 Senior Vice President and Chief Strategy Officer

Alfred Sandrock

56 2013 Group Senior Vice President, Chief Medical Officer

Gregory Covino

48 2012 Chief Accounting Officer, Vice President - Finance

Alexander Denner

2009 Independent Director

Caroline Dorsa

55 2010 Independent Director

Nancy Leaming

67 2008 Independent Director

Richard Mulligan

59 2009 Independent Director

Robert Pangia

62 1997 Independent Director

Brian Posner

52 2008 Independent Director

Eric Rowinsky

57 2010 Independent Director

Lynn Schenk

69 1995 Independent Director

Stephen Sherwin

65 2010 Independent Director
Search Stocks